Stock listing

RCUS Stock Price, News, Filings & Events — Arcus Biosciences, Inc.

Selected listing: RCUS · BOATS · USD · US

This page tracks Arcus Biosciences, Inc.'s RCUS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RCUS:BOATS. RCUS:BOATS is the stock-level entry point for investors researching Arcus Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arcus Biosciences, Inc. (ticker: RCUS) is a public company based in the United States, focusing on innovative cancer therapies. With a market capitalization of approximately $3.44 billion, Arcus is dedicated to advancing its research and development efforts in the biopharmaceutical sector. The company aims to improve treatment options for patients through its cutting-edge approaches in oncology.

RCUS:BOATSUSDUSUpdated August 28, 2026
Arcus Biosciences, Inc. logo
Ticker
RCUS:BOATS
Asset type
Stock
Market cap
$3.72B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Arcus Biosciences, Inc. RCUS:BOATS stock context

This page tracks Arcus Biosciences, Inc.'s RCUS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RCUS:BOATS. RCUS:BOATS is the stock-level entry point for investors researching Arcus Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arcus Biosciences, Inc. (ticker: RCUS) is a public company based in the United States, focusing on innovative cancer therapies. With a market capitalization of approximately $3.44 billion, Arcus is dedicated to advancing its research and development efforts in the biopharmaceutical sector. The company aims to improve treatment options for patients through its cutting-edge approaches in oncology.

Latest news from Arcus Biosciences, Inc.

All Arcus Biosciences, Inc. news →

Arcus Biosciences, Inc. earnings calls

Research Arcus Biosciences, Inc.

Alternate listings